Gyroscope Capital Management Group, LLC Bristol Myers Squibb CO Transaction History

Gyroscope Capital Management Group, LLC

$440 Million
Q3 2023

A detailed history of Gyroscope Capital Management Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gyroscope Capital Management Group, LLC holds 80,036 shares of BMY stock, worth $4.62 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

80,036

Previous 71,012 12.71%

Holding current value

$4.62 Million

Previous $4.54 Million 2.29%

% of portfolio

1.06%

Previous 1.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $522,399 - $584,123	9,024 Added 12.71%	80,036 $4.65 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $143,857 - $159,730	2,258 Added 3.28%	71,012 $4.54 Million
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $131,222 - $148,836	1,997 Added 2.99%	68,754 $4.77 Million
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $100,323 - $118,796	-1,465 Reduced 2.15%	66,757 $4.8 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $27 - $16,136	-210 Reduced 0.31%	68,222 $4.85 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $39,505 - $43,509	-544 Reduced 0.79%	68,432 $5.27 Million
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $7.14 Million - $8.56 Million	-116,147 Reduced 62.74%	68,976 $5.04 Million
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $696,171 - $811,572	12,981 Added 7.54%	185,123 $11.5 Million
Q3 2021 Oct 15, 2021	BUY	$59.17 - $69.31 $130,292 - $152,620	2,202 Added 1.3%	172,142 $10.2 Million
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $72,682 - $79,151	1,174 Added 0.7%	169,940 $11.4 Million
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $358,769 - $403,510	6,046 Added 3.72%	168,766 $10.7 Million
Q4 2020 Jan 29, 2021	SELL	$57.74 - $65.43 $195,796 - $221,873	-3,391 Reduced 2.04%	162,720 $10.1 Million
Q3 2020 Oct 14, 2020	SELL	$57.43 - $63.64 $4.17 Million - $4.62 Million	-72,548 Reduced 30.4%	166,111 $10 Million
Q2 2020 Jul 16, 2020	SELL	$54.82 - $64.09 $2.39 Million - $2.79 Million	-43,593 Reduced 15.44%	238,659 $14 Million
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $125,512 - $182,398	-2,705 Reduced 0.95%	282,252 $15.7 Million
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $6.64 Million - $8.66 Million	134,937 Added 89.95%	284,957 $18.3 Million
Q3 2019 Oct 11, 2019	SELL	$42.77 - $50.71 $258,587 - $306,592	-6,046 Reduced 3.87%	150,020 $7.43 Million
Q2 2019 Jul 11, 2019	BUY	$44.62 - $49.34 $103,072 - $113,975	2,310 Added 1.5%	156,066 $7.16 Million
Q1 2019 Apr 22, 2019	BUY	$45.12 - $53.8 $300,093 - $357,823	6,651 Added 4.52%	153,756 $7.15 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $7.17 Million - $9.3 Million	147,105 New	147,105 $7.65 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyroscope Capital Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gyroscope Capital Management Group, LLC with notifications on news.

Account

Gyroscope Capital Management Group, LLC Bristol Myers Squibb CO Transaction History